| 今开：46.09 | 昨收：46.07 |
| 最高：47.145 | 最低：45.19 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.591262085E9 |
二麻麻04-10 16:44
$Crinetics(CRNX)$ 最近很火的GLP-1 adjacent概念股。
在$诺和诺德(NVO)$ 母公司的年报里发现，也是Novo Venture的portfolio查看全文
Crinetics(CRNX)04-05 04:55
$Crinetics(CRNX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-087326 Act: 34 Size: 142 KB 网页链接查看全文
Crinetics(CRNX)04-16 04:25
$Crinetics(CRNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003070 Act: 33 Size: 6 KB 网页链接查看全文
Crinetics(CRNX)05-10 04:45
$Crinetics(CRNX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-057150 Act: 34 Size: 8 MB 网页链接查看全文
Crinetics(CRNX)04-26 04:55
$Crinetics(CRNX)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-048438 Act: 34 Size: 9 MB 网页链接查看全文
Crinetics(CRNX)06-12 04:25
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071930 Size: 7 KB 网页链接查看全文
Crinetics(CRNX)06-27 04:35
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-077905 Size: 5 KB 网页链接查看全文
Crinetics(CRNX)06-22 05:35
$Crinetics(CRNX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-165903 Act: 34 Size: 442 KB 网页链接查看全文
Crinetics(CRNX)06-29 05:35
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-079152 Size: 4 KB 网页链接查看全文
Crinetics(CRNX)04-26 04:55
$Crinetics(CRNX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-048439 Act: 34 Size: 3 MB 网页链接查看全文
牛股小红书2022-03-14 10:35
Frazier在2021年向上市药企$Crinetics制药(CRNX)$ 投资了1500万美元，建立了密切关系，当Crinetics推出非肽靶向放射性药物候选药物时，Frazier与之联合创立了生物技术公司Radionetics Oncology
$POINT Biopharma(PNT)$ $百济神州-U(SH688235)$查看全文
牛股小红书2022-03-01 13:05
2月28日，$Crinetics制药(CRNX)$ 和总部位于日本名古屋的制药公司 Sanwa Kagaku Kenkyusho Co., Ltd.（“Sanwa”）宣布，双方已建立战略合作伙伴关系，以在日本独家开发和商业化Paltusotine 。
Paltusotine 是 Crinetics 的研究性口服非肽类生长抑素受体 2 型 (SST2) 激动剂，被评估为治疗肢端...查看全文
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080557 Size: 8 KB 网页链接
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-079152 Size: 4 KB 网页链接
$Crinetics(CRNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005098 Act: 33 Size: 4 KB 网页链接
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-077905 Size: 5 KB 网页链接
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-077402 Size: 8 KB 网页链接
$Crinetics(CRNX)$ 144 Report of proposed sale of securities Accession Number: 0001969171-24-000027 Act: 33 Size: 6 KB 网页链接
$Crinetics(CRNX)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000929 Act: 33 Size: 4 KB 网页链接
$Crinetics(CRNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076871 Size: 8 KB 网页链接
$Crinetics(CRNX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-165984 Act: 33 Size: 545 KB 网页链接
$Crinetics(CRNX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-165903 Act: 34 Size: 442 KB 网页链接